Search for a command to run...
Epigral Ltd. stands out as a growth outperformer in the Chemicals sector, exhibiting solid revenue and EPS growth along with competitive profitability metrics. However, compared to its peers, it also shows attractive valuation ratios, making it a compelling investment choice.
Stock | CMP | Market Cap | P/E | ROE (%) | ROCE (%) | Debt/Equity |
|---|---|---|---|---|---|---|
| EPIGRAL | ₹1,697.60 | ₹7,325.61Cr | 16.94 | 16.86% | 17.69% | 0.77 |
| PIDILITIND | ₹1,460.50 | ₹1,48,611.69Cr | 66.75 | 23.21% | 31.16% | 0.02 |
| SOLARINDS | ₹14,161.00 | ₹1,28,112.65Cr | 101.54 | 29.59% | 31.03% | 0.33 |
| SRF | ₹2,968.10 | ₹87,981.85Cr | 54.39 | 12.27% | 12.83% | 0.43 |
| FLUOROCHEM | ₹3,728.30 | ₹40,862.55Cr | 65.70 | 8.31% | 10.02% | 0.28 |
| GODREJIND | ₹1,128.40 | ₹37,194.85Cr | 36.90 | 20.50% | 10.16% | 3.73 |
| NAVINFLUOR | ₹5,905.50 | ₹30,238.26Cr | 68.09 | 11.62% | 11.76% | 0.55 |